Clinical trial

Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage

NCT06166771

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Alma system Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-09-09

PhaseNA

Conditions

Postpartum Hemorrhage \(PPH\)unresolved

Postpartum Hemorrhage \(Primary\)unresolved

PPHunresolved

Interventions

Alma systemDEVICE

Sponsors & collaborators

ResQ Medical Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06166771 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.